 | • レポートコード：MRC2-11QY01423 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒト用混合ワクチンのグローバル市場について調査・分析したレポートです。種類別（ヒトコンビネーション不活化ワクチン、ヒトコンビネーション生弱毒ワクチン）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒト用混合ワクチンの競争状況、市場シェア ・世界のヒト用混合ワクチン市場：種類別市場規模 2015年-2020年（ヒトコンビネーション不活化ワクチン、ヒトコンビネーション生弱毒ワクチン） ・世界のヒト用混合ワクチン市場：種類別市場規模予測 2021年-2026年（ヒトコンビネーション不活化ワクチン、ヒトコンビネーション生弱毒ワクチン） ・世界のヒト用混合ワクチン市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のヒト用混合ワクチン市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のヒト用混合ワクチン市場分析：米国、カナダ ・ヨーロッパのヒト用混合ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒト用混合ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒト用混合ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒト用混合ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Sanofi、Daiichi Sankyo、Serum Institute of India、Takeda Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.
Market Analysis and Insights: Global Human Combination Vaccines Market
The global Human Combination Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Combination Vaccines Scope and Market Size
Human Combination Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Combination Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Combination Vaccines market is segmented into
Human Combination Inactivated Vaccines
Human Combination Live Attenuated Vaccines
Segment by Application, the Human Combination Vaccines market is segmented into
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Human Combination Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Combination Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Combination Vaccines Market Share Analysis
Human Combination Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Combination Vaccines business, the date to enter into the Human Combination Vaccines market, Human Combination Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Sanofi
Daiichi Sankyo
Serum Institute of India
Takeda Pharmaceuticals
…
1 Study Coverage
1.1 Human Combination Vaccines Product Introduction
1.2 Market Segments
1.3 Key Human Combination Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Combination Vaccines Market Size Growth Rate by Type
1.4.2 Human Combination Inactivated Vaccines
1.4.3 Human Combination Live Attenuated Vaccines
1.5 Market by Application
1.5.1 Global Human Combination Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Combination Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Human Combination Vaccines Revenue 2015-2026
2.1.2 Global Human Combination Vaccines Sales 2015-2026
2.2 Global Human Combination Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Combination Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Combination Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Combination Vaccines Competitor Landscape by Players
3.1 Human Combination Vaccines Sales by Manufacturers
3.1.1 Human Combination Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Human Combination Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Human Combination Vaccines Revenue by Manufacturers
3.2.1 Human Combination Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Human Combination Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Combination Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Combination Vaccines Revenue in 2019
3.2.5 Global Human Combination Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Combination Vaccines Price by Manufacturers
3.4 Human Combination Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Human Combination Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Combination Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Human Combination Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Combination Vaccines Market Size by Type (2015-2020)
4.1.1 Global Human Combination Vaccines Sales by Type (2015-2020)
4.1.2 Global Human Combination Vaccines Revenue by Type (2015-2020)
4.1.3 Human Combination Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Combination Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Combination Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Human Combination Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Human Combination Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Combination Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Combination Vaccines Market Size by Application (2015-2020)
5.1.1 Global Human Combination Vaccines Sales by Application (2015-2020)
5.1.2 Global Human Combination Vaccines Revenue by Application (2015-2020)
5.1.3 Human Combination Vaccines Price by Application (2015-2020)
5.2 Human Combination Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Combination Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Human Combination Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Combination Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Combination Vaccines by Country
6.1.1 North America Human Combination Vaccines Sales by Country
6.1.2 North America Human Combination Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Combination Vaccines Market Facts & Figures by Type
6.3 North America Human Combination Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Human Combination Vaccines by Country
7.1.1 Europe Human Combination Vaccines Sales by Country
7.1.2 Europe Human Combination Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Combination Vaccines Market Facts & Figures by Type
7.3 Europe Human Combination Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Combination Vaccines by Region
8.1.1 Asia Pacific Human Combination Vaccines Sales by Region
8.1.2 Asia Pacific Human Combination Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Combination Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Human Combination Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Combination Vaccines by Country
9.1.1 Latin America Human Combination Vaccines Sales by Country
9.1.2 Latin America Human Combination Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Combination Vaccines Market Facts & Figures by Type
9.3 Central & South America Human Combination Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Combination Vaccines by Country
10.1.1 Middle East and Africa Human Combination Vaccines Sales by Country
10.1.2 Middle East and Africa Human Combination Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Combination Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Human Combination Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Human Combination Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Human Combination Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Human Combination Vaccines Products Offered
11.3.5 Sanofi Related Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Description and Business Overview
11.4.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Daiichi Sankyo Human Combination Vaccines Products Offered
11.4.5 Daiichi Sankyo Related Developments
11.5 Serum Institute of India
11.5.1 Serum Institute of India Corporation Information
11.5.2 Serum Institute of India Description and Business Overview
11.5.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Serum Institute of India Human Combination Vaccines Products Offered
11.5.5 Serum Institute of India Related Developments
11.6 Takeda Pharmaceuticals
11.6.1 Takeda Pharmaceuticals Corporation Information
11.6.2 Takeda Pharmaceuticals Description and Business Overview
11.6.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Pharmaceuticals Human Combination Vaccines Products Offered
11.6.5 Takeda Pharmaceuticals Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Human Combination Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Combination Vaccines Market Estimates and Projections by Region
12.1.1 Global Human Combination Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Human Combination Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Human Combination Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Human Combination Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Human Combination Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Human Combination Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Human Combination Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Human Combination Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Human Combination Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Human Combination Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Combination Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Combination Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Combination Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Combination Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Combination Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Combination Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Human Combination Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Combination Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Combination Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Combination Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Combination Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Combination Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Combination Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Combination Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Combination Vaccines Market Segments
Table 2. Ranking of Global Top Human Combination Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Combination Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Human Combination Inactivated Vaccines
Table 5. Major Manufacturers of Human Combination Live Attenuated Vaccines
Table 6. Global Human Combination Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Human Combination Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Human Combination Vaccines Sales by Regions 2015-2020 (K MT)
Table 9. Global Human Combination Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Human Combination Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Combination Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Human Combination Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Combination Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Combination Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Combination Vaccines as of 2019)
Table 15. Human Combination Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Combination Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Combination Vaccines Price (2015-2020) (USD/MT)
Table 18. Human Combination Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Combination Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Human Combination Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 23. Global Human Combination Vaccines Sales Share by Type (2015-2020)
Table 24. Global Human Combination Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Combination Vaccines Revenue Share by Type (2015-2020)
Table 26. Human Combination Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 28. Global Human Combination Vaccines Sales Share by Application (2015-2020)
Table 29. North America Human Combination Vaccines Sales by Country (2015-2020) (K MT)
Table 30. North America Human Combination Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Human Combination Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Combination Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 34. North America Human Combination Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 36. North America Human Combination Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Human Combination Vaccines Sales by Country (2015-2020) (K MT)
Table 38. Europe Human Combination Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Human Combination Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Combination Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 42. Europe Human Combination Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 44. Europe Human Combination Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Combination Vaccines Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Human Combination Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Combination Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Combination Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Human Combination Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Human Combination Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Combination Vaccines Sales by Country (2015-2020) (K MT)
Table 54. Latin America Human Combination Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Combination Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Combination Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 58. Latin America Human Combination Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 60. Latin America Human Combination Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Combination Vaccines Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Human Combination Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Combination Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Combination Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Combination Vaccines Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Human Combination Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Combination Vaccines Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Human Combination Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Major Businesses
Table 81. Sanofi Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sanofi Product
Table 83. Sanofi Recent Development
Table 84. Daiichi Sankyo Corporation Information
Table 85. Daiichi Sankyo Description and Major Businesses
Table 86. Daiichi Sankyo Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Daiichi Sankyo Product
Table 88. Daiichi Sankyo Recent Development
Table 89. Serum Institute of India Corporation Information
Table 90. Serum Institute of India Description and Major Businesses
Table 91. Serum Institute of India Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Serum Institute of India Product
Table 93. Serum Institute of India Recent Development
Table 94. Takeda Pharmaceuticals Corporation Information
Table 95. Takeda Pharmaceuticals Description and Major Businesses
Table 96. Takeda Pharmaceuticals Human Combination Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Takeda Pharmaceuticals Product
Table 98. Takeda Pharmaceuticals Recent Development
Table 99. Global Human Combination Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Human Combination Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Human Combination Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Human Combination Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Human Combination Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Human Combination Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Human Combination Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Human Combination Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Human Combination Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Human Combination Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Human Combination Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Human Combination Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Human Combination Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Human Combination Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Human Combination Vaccines Players
Table 117. Human Combination Vaccines Customers List
Table 118. Human Combination Vaccines Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Combination Vaccines Product Picture
Figure 2. Global Human Combination Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Human Combination Inactivated Vaccines Product Picture
Figure 4. Human Combination Live Attenuated Vaccines Product Picture
Figure 5. Global Human Combination Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Human Combination Vaccines Report Years Considered
Figure 10. Global Human Combination Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Human Combination Vaccines Sales 2015-2026 (K MT)
Figure 12. Global Human Combination Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Human Combination Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global Human Combination Vaccines Sales Market Share by Region in 2019
Figure 15. Global Human Combination Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global Human Combination Vaccines Revenue Market Share by Region in 2019
Figure 17. Global Human Combination Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Human Combination Vaccines Revenue in 2019
Figure 19. Human Combination Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Human Combination Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global Human Combination Vaccines Sales Market Share by Type in 2019
Figure 22. Global Human Combination Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global Human Combination Vaccines Revenue Market Share by Type in 2019
Figure 24. Global Human Combination Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global Human Combination Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global Human Combination Vaccines Sales Market Share by Application in 2019
Figure 27. Global Human Combination Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global Human Combination Vaccines Revenue Market Share by Application in 2019
Figure 29. North America Human Combination Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Human Combination Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Human Combination Vaccines Sales Market Share by Country in 2019
Figure 32. North America Human Combination Vaccines Revenue Market Share by Country in 2019
Figure 33. U.S. Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Human Combination Vaccines Market Share by Type in 2019
Figure 38. North America Human Combination Vaccines Market Share by Application in 2019
Figure 39. Europe Human Combination Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Human Combination Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Human Combination Vaccines Sales Market Share by Country in 2019
Figure 42. Europe Human Combination Vaccines Revenue Market Share by Country in 2019
Figure 43. Germany Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Human Combination Vaccines Market Share by Type in 2019
Figure 54. Europe Human Combination Vaccines Market Share by Application in 2019
Figure 55. Asia Pacific Human Combination Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Human Combination Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Human Combination Vaccines Sales Market Share by Region in 2019
Figure 58. Asia Pacific Human Combination Vaccines Revenue Market Share by Region in 2019
Figure 59. China Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Human Combination Vaccines Market Share by Type in 2019
Figure 82. Asia Pacific Human Combination Vaccines Market Share by Application in 2019
Figure 83. Latin America Human Combination Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Human Combination Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Human Combination Vaccines Sales Market Share by Country in 2019
Figure 86. Latin America Human Combination Vaccines Revenue Market Share by Country in 2019
Figure 87. Mexico Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Human Combination Vaccines Market Share by Type in 2019
Figure 94. Latin America Human Combination Vaccines Market Share by Application in 2019
Figure 95. Middle East and Africa Human Combination Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Human Combination Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Human Combination Vaccines Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Human Combination Vaccines Revenue Market Share by Country in 2019
Figure 99. Turkey Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Human Combination Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Human Combination Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Human Combination Vaccines Market Share by Type in 2019
Figure 106. Middle East and Africa Human Combination Vaccines Market Share by Application in 2019
Figure 107. North America Human Combination Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Human Combination Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Human Combination Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Human Combination Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Human Combination Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Human Combination Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Human Combination Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Human Combination Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Human Combination Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Human Combination Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヒトパピローマウイルス（HPV）ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus (HPV) Vaccines Market The global Human Papillomavirus (HPV) Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus (HPV) Vaccines Scope a…- フルミストワクチンの世界市場（～2026年） An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated…
- ヒトサイトメガロウイルス65kDaリンタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Human cytomegalovirus 65 kDa Phosphoprotein Market The global Human cytomegalovirus 65 kDa Phosphoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human cytomegalovirus 65 kD…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- 併用抗体療法の世界市場（～2026年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…